Alan J Gelenberg

Summary

Affiliation: Healthcare Technology Systems
Country: USA

Publications

  1. ncbi request reprint The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies
    Alan J Gelenberg
    Healthcare Technology Systems, 7617 Mineral Point Rd, Suite 300, Madison, WI 53717, USA
    J Clin Psychiatry 69:1513-28. 2008
  2. doi request reprint Using assessment tools to screen for, diagnose, and treat major depressive disorder in clinical practice
    Alan J Gelenberg
    Healthcare Technology Systems, Inc, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, USA
    J Clin Psychiatry 71:e01. 2010
  3. ncbi request reprint Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724 5002, USA
    Biol Psychiatry 54:806-17. 2003
  4. pmc Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021, USA
    J Affect Disord 110:55-61. 2008
  5. pmc Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA
    Arch Gen Psychiatry 66:1178-88. 2009
  6. ncbi request reprint Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 30:405-16. 2005
  7. ncbi request reprint Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial
    H George Nurnberg
    Department of Psychiatry, Health Sciences Center, University of New Mexico School of Medicine, 2400 Tucker NE, Albuquerque, NM 87131 5288, USA
    JAMA 289:56-64. 2003
  8. ncbi request reprint Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
    J Clin Psychiatry 68:1014-23. 2007
  9. ncbi request reprint REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Psychopharmacol Bull 41:5-33. 2008
  10. ncbi request reprint The state of knowledge of chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Arizona Health Sciences Center, Tucson, AZ, USA
    J Clin Psychiatry 67:179-84. 2006

Detail Information

Publications27

  1. ncbi request reprint The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies
    Alan J Gelenberg
    Healthcare Technology Systems, 7617 Mineral Point Rd, Suite 300, Madison, WI 53717, USA
    J Clin Psychiatry 69:1513-28. 2008
    ..With this in mind, a group of experts was convened under the auspices of the University of Arizona Department of Psychiatry and Best Practice Project Management, Inc...
  2. doi request reprint Using assessment tools to screen for, diagnose, and treat major depressive disorder in clinical practice
    Alan J Gelenberg
    Healthcare Technology Systems, Inc, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, USA
    J Clin Psychiatry 71:e01. 2010
    ..Assessment tools are available in many languages. Treatment algorithms can rationalize decision making, and collaborative care can speed and enhance treatment results...
  3. ncbi request reprint Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724 5002, USA
    Biol Psychiatry 54:806-17. 2003
    ..This randomized, placebo-controlled study of the efficacy and safety of nefazodone in preventing recurrence was conducted for patients with chronic MDD...
  4. pmc Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021, USA
    J Affect Disord 110:55-61. 2008
    ..These results and the consistency of similar results over time point to the dire need for patient and provider education regarding the signs and symptoms of depression and its treatment...
  5. pmc Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA
    Arch Gen Psychiatry 66:1178-88. 2009
    ..Previous studies have found that few chronically depressed patients remit with antidepressant medications alone...
  6. ncbi request reprint Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 30:405-16. 2005
    ..Global patient ratings such as the PGI-I, as opposed to specific item-based ratings, provide less valid findings...
  7. ncbi request reprint Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial
    H George Nurnberg
    Department of Psychiatry, Health Sciences Center, University of New Mexico School of Medicine, 2400 Tucker NE, Albuquerque, NM 87131 5288, USA
    JAMA 289:56-64. 2003
    ..Sexual dysfunction is a common adverse effect of antidepressants that frequently results in treatment noncompliance...
  8. ncbi request reprint Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
    J Clin Psychiatry 68:1014-23. 2007
    ..To test the long-term efficacy and safety of venlafaxine extended-release (ER) in preventing recurrence in patients with major depression...
  9. ncbi request reprint REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Psychopharmacol Bull 41:5-33. 2008
    ....
  10. ncbi request reprint The state of knowledge of chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Arizona Health Sciences Center, Tucson, AZ, USA
    J Clin Psychiatry 67:179-84. 2006
  11. ncbi request reprint Report by the ACNP Task Force on response and remission in major depressive disorder
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 31:1841-53. 2006
    ..Research to evaluate these recommendations empirically is needed...
  12. ncbi request reprint Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination
    John Zajecka
    Department of Psychiatry, Rush Presbyterian St Luke s Medical Center, 1725 W Harrison Street, Suite 955, Chicago, IL 60612, USA
    J Clin Psychiatry 63:709-16. 2002
    ..This study compares the effects of antidepressant medication, psychotherapy, and combined treatment on sexual interest/satisfaction and function in patients with chronic major depression...
  13. doi request reprint A review of the current guidelines for depression treatment
    Alan J Gelenberg
    Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania, USA
    J Clin Psychiatry 71:e15. 2010
    ..Despite progress made during the last decade, no major breakthroughs in the treatment of depression have occurred, and genetic testing developments allowing for personalized care remain the goal of research...
  14. doi request reprint The prevalence and impact of depression
    Alan J Gelenberg
    Healthcare Technology Systems, Inc, Madison, Wisconsin, USA
    J Clin Psychiatry 71:e06. 2010
    ..To combat these negative consequences, clinicians need to be as steadfast as ever to control this disorder and help patients lead symptom-free lives...
  15. ncbi request reprint Matching the bipolar patient and the mood stabilizer
    Alan J Gelenberg
    Department of Psychiatry, Arizona Health Sciences Center, Tucson, Arizona 85724 5002, USA
    Ann Clin Psychiatry 15:203-16. 2003
    ..Randomized, controlled studies in bipolar populations are needed to further characterize optimal matching of patient and medication...
  16. ncbi request reprint Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes
    Monique M Williams
    Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Diabetes Care 30:801-6. 2007
    ..A secondary analysis was performed to assess this effect in younger and older subsets of patients...
  17. ncbi request reprint Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002
    Thomas Delate
    Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
    Psychiatr Serv 55:387-91. 2004
    ..The aim of this study was to estimate the prevalence of use of prescription antidepressants among children and adolescents by using nationwide data and to examine trends in use from 1998 to 2002...
  18. doi request reprint Performance improvement CME: improving outcomes in depression
    Alan J Gelenberg
    Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania, USA
    J Clin Psychiatry 71:e19. 2010
    ..This PI CME focuses on improving the detection and initial treatment of depression, enhancing patients' treatment response, and preventing relapse and recurrence...
  19. doi request reprint Feasibility and validation of a computer-automated Columbia-Suicide Severity Rating Scale using interactive voice response technology
    James C Mundt
    Healthcare Technology Systems, Inc, 7617 Mineral Point Road, Ste 300, Madison, WI 53717, USA
    J Psychiatr Res 44:1224-8. 2010
    ....
  20. ncbi request reprint Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O Hara St, Pittsburgh, PA 15213, USA
    Arch Gen Psychiatry 59:233-9. 2002
    ..Although various strategies have been proposed to treat antidepressant nonresponders, little controlled research has been published that examines prospectively the use of switching to an alternate antidepressant...
  21. ncbi request reprint Metabolic effects of treatment with atypical antipsychotics
    John M Kane
    Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA
    J Clin Psychiatry 65:1447-55. 2004
  22. ncbi request reprint Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression
    H George Nurnberg
    Department of Psychiatry, Health Sciences Center, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131 5286, USA
    Urology 60:58-66. 2002
    ..Given the complex interrelations among ED, depression, and other comorbid conditions, the key to proper management is a comprehensive evaluation, including sexual function, and an accurate differential diagnosis...
  23. ncbi request reprint Smoking cessation in patients with psychiatric disorders
    Alan J Gelenberg
    Department of Psychiatry, University of Arizona, Tucson, USA
    J Clin Psychiatry 68:1404-10. 2007
  24. doi request reprint Depression symptomatology and neurobiology
    Alan J Gelenberg
    Healthcare Technology Systems, Inc, Madison, Wisconsin, USA
    J Clin Psychiatry 71:e02. 2010
    ..Neuroimaging, pharmacology, and genomics are among the sources of information that have contributed to theories about the pathophysiology of MDD and may lead to truly personalized medicine in the future...
  25. ncbi request reprint Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder
    Mukund Gnanadesikan
    Department of Psychiatry, University of Arizona, Tuscon 85724, USA
    Bipolar Disord 5:203-16. 2003
    ....
  26. ncbi request reprint Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients
    Pedro L Delgado
    Department of Psychiatry, Case Western Researve University School of Medicine, Cleveland, OH 44106 5080, USA
    Int J Neuropsychopharmacol 5:63-6. 2002
    ..Mood response to tryptophan or catecholamine depletion is dependent on the pharmacological properties of the antidepressant being taken during depletion...
  27. doi request reprint Optimizing depression treatment to increase the likelihood of remission
    Alan J Gelenberg
    Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania, USA
    J Clin Psychiatry 71:e22. 2010
    ....